Daniel Cox
Chief Financial Officer at FinGo- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
FinGo
-
United Kingdom
-
Financial Services
-
1 - 100 Employee
-
Chief Financial Officer
-
Mar 2017 - Present
London, United Kingdom An innovative startup fintech business with huge ambitions having created FinGo, the first cloud match ID based service enabling payments, loyalty, entry&access and age verification to name a few. Having been through a number of successful funding rounds the business is now poised to push this exciting Technology to the global market. As an investor in Sthaler my role on the Board involves all aspects of Strategic Finance and Business Operations including Company Secretarial duties.
-
-
-
-
Director
-
Apr 2015 - Mar 2017
London, United Kingdom A dynamic specialist logistics and removals organisation embarking on a strategy of growth through acquisition following private equity funding. As a shareholder and key member of the Board my role focused on strategy, governance, board & shareholder information, acquisition activity, performance and financial management.
-
-
-
Almirall
-
Spain
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Finance Director
-
Apr 2009 - Mar 2015
Uxbridge Almirall is a mid-size pharmaceutical company headquartered in Spain previously specialising in the sale of Dermatology & Respiratory products (global turnover €1bn). European expansion plans led to the creation of a UK subsidiary at the start of 2008 to launch into the UK market. I was appointed with full responsibility for all aspects of UK Finance, IT, Purchasing and Logistics. The initial remit involved understanding, recommending and implementing necessary structures for UK Finance.… Show more Almirall is a mid-size pharmaceutical company headquartered in Spain previously specialising in the sale of Dermatology & Respiratory products (global turnover €1bn). European expansion plans led to the creation of a UK subsidiary at the start of 2008 to launch into the UK market. I was appointed with full responsibility for all aspects of UK Finance, IT, Purchasing and Logistics. The initial remit involved understanding, recommending and implementing necessary structures for UK Finance. Key product launches into new therapeutic areas provided a unique opportunity to develop and grow my strategic and commercial skills alongside my key finance responsibilities. Show less
-
-
-
Recordati
-
Italy
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Finance & Administration Manager
-
Jul 2006 - Mar 2009
UK Recordati is a mid-size pharmaceutical company headquartered in Milan, Italy specializing in cardiovascular product sales throughout Europe (total sales €600m). European expansion plans led to the creation of a UK subsidiary at the start of 2006 to promote and sell its’ key product Zanidip whilst actively seeking new products to launch into the UK market. I was appointed as Finance and Admin Manager with full responsibility for all aspects of UK Finance and Logistics. Given the startup nature… Show more Recordati is a mid-size pharmaceutical company headquartered in Milan, Italy specializing in cardiovascular product sales throughout Europe (total sales €600m). European expansion plans led to the creation of a UK subsidiary at the start of 2006 to promote and sell its’ key product Zanidip whilst actively seeking new products to launch into the UK market. I was appointed as Finance and Admin Manager with full responsibility for all aspects of UK Finance and Logistics. Given the startup nature of the UK subsidiary, processes needed to be setup before they could be maintained. Show less
-
-
-
UCB
-
Belgium
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
European Regional Financial Controller
-
Jul 2004 - Jun 2006
Brussels UCB Pharma is a pharmaceutical company listed on the Belgian stock exchange and specializing in allergy and neurology product sales of €2,000m. Their R&D pipeline was broadened in July 2004 following the acquisition of the Celltech Group PLC. In this Regional role covering Eastern Europe, Russia and Turkey (sales €100m), I gained important experience supporting a Divisional Commercial Director launching in new markets as well as operating in mature and mid growth markets. Key to this role… Show more UCB Pharma is a pharmaceutical company listed on the Belgian stock exchange and specializing in allergy and neurology product sales of €2,000m. Their R&D pipeline was broadened in July 2004 following the acquisition of the Celltech Group PLC. In this Regional role covering Eastern Europe, Russia and Turkey (sales €100m), I gained important experience supporting a Divisional Commercial Director launching in new markets as well as operating in mature and mid growth markets. Key to this role was balancing critical Commercial support with ensuring the day to day finance and performance management model ran smoothly and in line with expectations. Show less
-
-
-
-
Pharma Group Accountant / Asst Finance Manager
-
Sep 2001 - Jun 2004
Slough, United Kingdom The Celltech group was listed on the FTSE 250 before being acquired by UCB in 2004. These roles in a Biotech HQ gave me exposure to Divisional management of both the Commercial and the R&D side of the Pharmaceuticals industry.
-
-
-
-
Financial Accountant / Management Accountant
-
Dec 1998 - Aug 2001
Slough, United Kingdom
-
-
-
-
General Ledger Accountant / Purchase Ledger Superviser
-
Mar 1996 - Nov 1998
Basingstoke
-
-
-
Centerprise International
-
United Kingdom
-
IT Services and IT Consulting
-
100 - 200 Employee
-
Purchase Ledger Clerk
-
Sep 1994 - Feb 1996
Basingstoek
-
-
Education
-
The Chartered Institute of Management Accountants
ACMA Qualified -
The Gap Partnership
"The Complete Skilled Negotiator" trained -
The Association of Accounting Technicians
AAT Qualified